[Countermeasures for respiratory failure of chronic obstructive lung disease].
Hasegawa
S
S
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018680:Cholinergic Antagonists / Q000008:administration & dosage; D018450:Disease Progression; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D012944:Social Support; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D018680:Cholinergic Antagonists; D013256:Steroids